Clinical Trials Directory

Trials / Unknown

UnknownNCT02307383

Pilot Study of the Effectiveness of Probiotics and Lactitol for the Decolonization of OXA-48 (Carbapenemase) Producing Klebsiella Pneumoniae Among Rectal Carriers

Pilot Study of the Effectiveness of Probiotics and Lactitol for the Intestinal Decolonization of People Carriers of Klebsiella Pneumoniae Producers of Carbapenemase OXA-48-type: DesProbiOXA Study

Status
Unknown
Phase
Phase 2
Study type
Interventional
Enrollment
20 (estimated)
Sponsor
Instituto de Investigación Hospital Universitario La Paz · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The combination of Lactitol and Probiotics (Lactobacillus acidophilus and Lactobacillus Biphidus) administered orally is an effective strategy of intestinal decolonization of Enterobacter produced OXA-48-type carbapenemase. The purpose of this study is to determine the effectiveness of Lactitol and Probiotics for the intestinal decolonization of people who carried Klebsiella pneumoniae produced OXA-48-type Carbapenemase.

Conditions

Interventions

TypeNameDescription
DRUGLactitol
DRUGLactobacillus

Timeline

Start date
2014-10-01
Primary completion
2015-10-01
Completion
2015-10-01
First posted
2014-12-04
Last updated
2014-12-05

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT02307383. Inclusion in this directory is not an endorsement.